Core Laboratories NV (CLB)
Core Laboratories Inc. specializes in reservoir description and production enhancement services for the oil and gas industry globally, with operations in two segments: Reservoir Description and Production Enhancement. The company offers a range of services, including laboratory analyses, field services, and products for oil and gas reservoirs, supporting enhanced recovery and various energy projects, marketed through sales representatives, seminars, trade shows, and advertising.
Company Info
| ISIN | US21867A1051 |
|---|---|
| CUSIP | N22717107 |
| Sector | Energy |
| Industry | Oil & Gas Equipment & Services |
Highlights
| Market Cap | $790.49M |
|---|---|
| EPS | $0.51 |
| PE Ratio | 33.22 |
| PEG Ratio | 2.15 |
| Revenue (TTM) | $511.07M |
| Gross Profit (TTM) | $96.08M |
| EBITDA (TTM) | $74.51M |
| Year Range | $13.82 - $27.90 |
| Target Price | $19.50 |
| Short % | 23.36% |
| Short Ratio | 16.17 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Core Laboratories NV, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Core Laboratories NV had a return of -10.98% year-to-date (YTD) and -26.06% in the last 12 months. Over the past 10 years, Core Laboratories NV had an annualized return of -21.02%, while the S&P 500 had an annualized return of 10.33%, indicating that Core Laboratories NV did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -10.98% | 5.21% |
| 1 month | -8.29% | -4.30% |
| 6 months | -25.17% | 18.42% |
| 1 year | -26.06% | 21.82% |
| 5 years (annualized) | -23.13% | 11.27% |
| 10 years (annualized) | -21.02% | 10.33% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -10.70% | -5.01% | 14.09% | -7.49% | ||||||||
| 2023 | -10.79% | -17.28% | -0.28% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of CLB is 23, indicating that it is in the bottom 23% of the market in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
Core Laboratories NV(CLB)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Core Laboratories NV (CLB) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Core Laboratories NV granted a 0.25% dividend yield in the last twelve months. The annual payout for that period amounted to $0.04 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.04 | $0.04 | $0.04 | $0.04 | $0.28 | $2.20 | $2.20 | $2.20 | $2.20 | $2.67 | $2.00 | $1.28 |
Dividend yield | 0.25% | 0.23% | 0.20% | 0.18% | 1.06% | 5.84% | 3.69% | 2.01% | 1.83% | 2.45% | 1.66% | 0.67% |
Monthly Dividends
The table displays the monthly dividend distributions for Core Laboratories NV. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | $0.01 | $0.00 | $0.00 | ||||||||
| 2023 | $0.00 | $0.01 | $0.00 | $0.00 | $0.01 | $0.00 | $0.00 | $0.01 | $0.00 | $0.00 | $0.01 | $0.00 |
| 2022 | $0.00 | $0.01 | $0.00 | $0.00 | $0.01 | $0.00 | $0.00 | $0.01 | $0.00 | $0.00 | $0.01 | $0.00 |
| 2021 | $0.01 | $0.00 | $0.00 | $0.01 | $0.00 | $0.00 | $0.00 | $0.01 | $0.00 | $0.00 | $0.01 | $0.00 |
| 2020 | $0.25 | $0.00 | $0.00 | $0.00 | $0.01 | $0.00 | $0.01 | $0.00 | $0.00 | $0.01 | $0.00 | $0.00 |
| 2019 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 |
| 2018 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 |
| 2017 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 |
| 2016 | $0.55 | $0.00 | $0.00 | $0.00 | $0.55 | $0.00 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 |
| 2015 | $1.02 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 |
| 2014 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 |
| 2013 | $0.32 | $0.00 | $0.00 | $0.32 | $0.00 | $0.00 | $0.32 | $0.00 | $0.00 | $0.32 | $0.00 | $0.00 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Core Laboratories NV. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Core Laboratories NV was 95.76%, occurring on Mar 17, 2020. The portfolio has not yet recovered.
The current Core Laboratories NV drawdown is 91.61%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -95.76% | Apr 22, 2014 | 1487 | Mar 17, 2020 | — | — | — |
| -74.19% | Apr 4, 2000 | 631 | Oct 9, 2002 | 706 | Jul 29, 2005 | 1337 |
| -65.38% | Nov 7, 2007 | 277 | Dec 11, 2008 | 341 | Apr 22, 2010 | 618 |
| -59.07% | May 13, 1998 | 77 | Aug 31, 1998 | 401 | Apr 3, 2000 | 478 |
| -35.01% | Nov 12, 1997 | 29 | Dec 23, 1997 | 60 | Mar 23, 1998 | 89 |
Volatility
Volatility Chart
The current Core Laboratories NV volatility is 10.29%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |